UCB Case Study: Open Innovation and Risk Sharing Partnerships – What are the Benefits and Practicalities?

Posted: 01/12/2011
To continue viewing this content please fill out the form below and become an Pharma IQ member.
Or if you're already a Pharma IQ member, sign in below to download.
Join

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.

In this UCB case study Patrice Talaga, Director Chemistry Outsourcing, UCB, provides an overview of open innovation and the set up practicalities. Talaga discusses how to find new, innovative models to replenish the pipeline and whether operational excellence and open innovation are compatible. He also shares his insights on the requirements for successful open innovation.

Presented at Pharma IQ's Global Discovery Outsourcing and Collaborations Forum in October 2010.

Contributor: